论文部分内容阅读
目的：癌性出血是癌症患者的死因之一，本文观察立止血在癌性出血治疗中的作用。方法：我们对31例癌症出血患者使用立止血，对癌性出血按照出血量和出血部位进行了统计和分析，并观察其有效率。结果：总有效率为87．1％，其中大量出血有效率为25％，中量出血有效率66．7％，小量出血有效率为100％。结论：立止血的止血作用迅速、持续时间长，其疗效较安络血、止血敏等好，临床上可作为癌性出血的首选药之一。
Objective: Cancerous bleeding is one of the causes of death in cancer patients. This article observed the role of Reptilase in the treatment of cancerous bleeding. METHODS: We used stabile hemostasis in 31 patients with cancer hemorrhage. We performed statistics and analysis of hemorrhage and bleeding sites for cancerous bleeding and observed its effectiveness. Results: The total effective rate was 87.1%, of which the effective rate of massive hemorrhage was 25%, the effective rate of moderate hemorrhage was 66.7%, and the effective rate of small amount of hemorrhage was 100%. Conclusion: Lithostatic hemostasis has the advantages of rapid hemostasis and long duration, and its efficacy is better than that of Anluo blood and hemostasis. It can be used clinically as one of the first choices for cancerous hemorrhage.